secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOLOGIC INC (—)
CIK:        0000859737
Form:       8-K/A
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001140361-24-024213
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hologic Q2 beats: revenue $1,018M, adj EPS $1.03; raises FY24 guidance; acquires Endomagnetics for $310M
--------------------------------------------------------------------------------

- Q2 revenue $1,017.8M (down 0.8% YoY) exceeded guidance; GAAP diluted EPS $0.72, non-GAAP $1.03.
- Organic revenue ex-COVID grew 4.9% constant currency; Diagnostics ex-COVID +9.8%, Surgical +7.4%.
- Company raised full-year revenue midpoint in constant currency and EPS guidance on strong margins.
- Agreed to acquire Endomagnetics Ltd for ~$310M, adding breast cancer surgery technologies.
- Cash flow from operations $292.4M; cash generation remains strong.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/859737/000114036124024213/0001140361-24-024213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/859737/000114036124024213/ef20028431_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-024213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer